Efficacy of cannabinoids compared to the current standard treatments on symptom relief in persons with multiple sclerosis (CANSEP trial): study protocol for a randomized clinical trial

Overview of attention for article published in Frontiers in Neurology, July 2024

Altmetric Badge

Mentioned by

twitter: 2 X users

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 28,874 followers.

Efficacy of cannabinoids compared to the current standard treatments on symptom relief in persons with multiple sclerosis (CANSEP trial): study protocol for a randomized clinical trial #FrontiersIn #Neurology https://t.co/aq4n2scbNu… https://t.co/P0dMSP9QQ

24 Jul 2024

Reply Repost Favourite

New Research: Efficacy of cannabinoids compared to the current standard treatments on symptom relief in persons with multiple sclerosis (CANSEP trial): study protocol for a randomized clinical trial https://t.co/yZuOPuZxBg #FrontiersIn #Neurology

24 Jul 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.